SoP Library › Olecranon bursitis

Statement of Principles

Olecranon bursitis — DVA SoP factors

Every factor in the Repatriation Medical Authority Statements of Principles for Olecranon bursitis. DVA can only accept a claim for Olecranon bursitis if at least one of these factors is met and connected to your service. Reasonable Hypothesis (RH) applies to operational service; Balance of Probabilities (BoP) applies to peacetime service.

Source: Repatriation Medical Authority Statements of Principles as held by the Veterans Health Centre. SoPs are amended and replaced regularly; always confirm the current instrument at rma.gov.au before relying on it.

Olecranon bursitis

RH No. 63 of 2018 · BoP No. 64 of 201830 factors

Meaning of olecranon bursitis: For the purposes of this Statement of Principles, olecranon bursitis means inflammation or infection of the bursa overlying the olecranon process of the ulna.

Reasonable Hypothesis (RH) — Statement of Principles No. 63 of 2018

At least one of the following factors must as a minimum exist before it can be said that a reasonable hypothesis has been raised connecting olecranon bursitis or death from olecranon bursitis with the circumstances of a person's relevant service:

  1. (1)
    having a bacterial, fungal or algal infection involving the affected bursa at the time of the clinical onset of olecranon bursitis;
  2. (2)
    having trauma to the external elbow of the affected side in the 30 days before the clinical onset of olecranon bursitis;

    Note: Examples of types of trauma include cuts, abrasions and lacerations of the affected elbow, repeated rubbing or knocking of the affected elbow, needle aspiration of the affected olecranon bursa and injection of the affected olecranon bursa with corticosteroids.

  3. (3)
    having surgery to the external elbow of the affected side in the 30 days before the clinical onset of olecranon bursitis;
  4. (4)
    for septic olecranon bursitis only, being in an immunocompromised state as specified at the time of the clinical onset of olecranon bursitis;

    Note: immunocompromised state as specified is defined in the Schedule 1 - Dictionary.

  5. (5)
    having a disorder from the specified list of disorders at the time of the clinical onset of olecranon bursitis;

    Note: specified list of disorders is defined in the Schedule 1 - Dictionary.

  6. (6)
    having psoriasis, localised sclerosis, atopic dermatitis or another inflammatory skin disorder, where the skin disorder involves the skin of the extensor surface of the affected elbow, at the time of the clinical onset of olecranon bursitis;
  7. (7)
    being treated with a tyrosine kinase inhibitor within the 30 days before the clinical onset of olecranon bursitis;
  8. (8)
    having a bacterial, fungal or algal infection involving the affected bursa at the time of the clinical worsening of olecranon bursitis;
  9. (9)
    having trauma to the external elbow of the affected side in the 30 days before the clinical worsening of olecranon bursitis;

    Note: Examples of types of trauma include cuts, abrasions and lacerations of the affected elbow, repeated rubbing or knocking of the affected elbow, needle aspiration of the affected olecranon bursa and injection of the affected olecranon bursa with corticosteroids.

  10. (10)
    having surgery to the external elbow of the affected side in the 30 days before the clinical worsening of olecranon bursitis;
  11. (11)
    for septic olecranon bursitis only, being in an immunocompromised state as specified at the time of the clinical worsening of olecranon bursitis;

    Note: immunocompromised state as specified is defined in the Schedule 1 - Dictionary.

  12. (12)
    having a disorder from the specified list of disorders at the time of the clinical worsening of olecranon bursitis;

    Note: specified list of disorders is defined in the Schedule 1 - Dictionary.

  13. (13)
    having psoriasis, localised sclerosis, atopic dermatitis or another inflammatory skin disorder, where the skin disorder involves the skin of the extensor surface of the affected elbow, at the time of the clinical worsening of olecranon bursitis;
  14. (14)
    being treated with a tyrosine kinase inhibitor within the 30 days before the clinical worsening of olecranon bursitis;
  15. (15)
    inability to obtain appropriate clinical management for olecranon bursitis;

Aggravation-only factors: the factors in subsections 8(8) to 8(15) apply only to material contribution to, or aggravation of, the condition where it was suffered or contracted before or during (but did not arise out of) the person’s relevant service.

Balance of Probabilities (BoP) — Statement of Principles No. 64 of 2018

15 factors

At least one of the following factors must exist before it can be said that, on the balance of probabilities, olecranon bursitis or death from olecranon bursitis is connected with the circumstances of a person's relevant service:

  1. (1)
    having a bacterial, fungal or algal infection involving the affected bursa at the time of the clinical onset of olecranon bursitis;
  2. (2)
    having trauma to the external elbow of the affected side in the 30 days before the clinical onset of olecranon bursitis;

    Note: Examples of types of trauma include cuts, abrasions and lacerations of the affected elbow, repeated rubbing or knocking of the affected elbow, needle aspiration of the affected olecranon bursa and injection of the affected olecranon bursa with corticosteroids.

  3. (3)
    having surgery to the external elbow of the affected side in the 30 days before the clinical onset of olecranon bursitis;
  4. (4)
    for septic olecranon bursitis only, being in an immunocompromised state as specified at the time of the clinical onset of olecranon bursitis;

    Note: immunocompromised state as specified is defined in the Schedule 1 - Dictionary.

  5. (5)
    having a disorder from the specified list of disorders at the time of the clinical onset of olecranon bursitis;

    Note: specified list of disorders is defined in the Schedule 1 - Dictionary.

  6. (6)
    having psoriasis, localised sclerosis, atopic dermatitis or another inflammatory skin disorder, where the skin disorder involves the skin of the extensor surface of the affected elbow, at the time of the clinical onset of olecranon bursitis;
  7. (7)
    being treated with a tyrosine kinase inhibitor within the 30 days before the clinical onset of olecranon bursitis;
  8. (8)
    having a bacterial, fungal or algal infection involving the affected bursa at the time of the clinical worsening of olecranon bursitis;
  9. (9)
    having trauma to the external elbow of the affected side in the 30 days before the clinical worsening of olecranon bursitis;

    Note: Examples of types of trauma include cuts, abrasions and lacerations of the affected elbow, repeated rubbing or knocking of the affected elbow, needle aspiration of the affected olecranon bursa and injection of the affected olecranon bursa with corticosteroids.

  10. (10)
    having surgery to the external elbow of the affected side in the 30 days before the clinical worsening of olecranon bursitis;
  11. (11)
    for septic olecranon bursitis only, being in an immunocompromised state as specified at the time of the clinical worsening of olecranon bursitis;

    Note: immunocompromised state as specified is defined in the Schedule 1 - Dictionary.

  12. (12)
    having a disorder from the specified list of disorders at the time of the clinical worsening of olecranon bursitis;

    Note: specified list of disorders is defined in the Schedule 1 - Dictionary.

  13. (13)
    having psoriasis, localised sclerosis, atopic dermatitis or another inflammatory skin disorder, where the skin disorder involves the skin of the extensor surface of the affected elbow, at the time of the clinical worsening of olecranon bursitis;
  14. (14)
    being treated with a tyrosine kinase inhibitor within the 30 days before the clinical worsening of olecranon bursitis;
  15. (15)
    inability to obtain appropriate clinical management for olecranon bursitis;

Aggravation-only factors: the factors in subsections 8(8) to 8(15) apply only to material contribution to, or aggravation of, the condition where it was suffered or contracted before or during (but did not arise out of) the person’s relevant service.

A VHC Diagnostic Assessment addresses each of these factors one by one against your service record and clinical history. See how a VHC DVA claim works, see all fees ($600 + GST per stage) or book an appointment.

Accepted — what is it worth?

A Statement of Principles decides one thing only: whether DVA accepts liability for olecranon bursitis. It says nothing about how much you are paid. Compensation is worked out separately, from impairment points under the GARP — so a condition can be accepted and still rate few points, or rate more than you expect once it is combined with everything else on your file.

Part of DVA Claims — Shoulders & arms — every Statement of Principles covering the shoulders and arms.

Others in this area:

Dr Thomas Perkins, Veterans Health Centre

Reviewed by Dr Thomas Perkins

Founding doctor, Veterans Health Centre · former RAAF aviation medical officer · 13 years working exclusively with ADF members and veterans. Full profile →